Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peroxisome proliferator-activated receptor (PPAR) gamma in cardiovascular disorders and cardiovascular surgery

Published:2015-10 Issue:4 Volume:66 Page:271-278
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Ivanova Ekaterina A.,Parolari Alessandro,Myasoedova Veronika,Melnichenko Alexandra A.,Bobryshev Yuri V.,Orekhov Alexander N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference121 articles.

1. Nuclear receptors: nomenclature, ligands, mechanisms of their effects on gene expression;Smirnov;Biochemistry,2002

2. Peroxisome proliferator-activated receptors: from genes to physiology;Kliewer;Recent Prog Horm Res,2001

3. Gene expression changes induced by PPAR gamma agonists in animal and human liver;Rogue;PPAR Res,2010

4. PPARs integrate the mammalian clock and energy metabolism;Chen;PPAR Res,2014

5. Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease;Boitier;Comp Hepatol,2003

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Joint effects of PPARG-C161T (rs3856806) polymorphism and cardiovascular risk factors on restenosis risk after coronary stent implantation;Turkish Journal of Biochemistry;2024-06-14

2. Pistacia lentiscus: Phytochemistry and Antidiabetic Properties;Nutrients;2024-05-27

3. PPARγ Agonist Rosiglitazone and Antagonist GW9662: Antihypertensive Effects on Chronic Intermittent Hypoxia-Induced Hypertension in Rats;Journal of Cardiovascular Translational Research;2024-02-27

4. Edaravone and obeticholic acid protect against cisplatin-induced heart toxicity by suppressing oxidative stress and inflammation and modulating Nrf2, TLR4/p38MAPK, and JAK1/STAT3/NF-κB signals;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-29

5. Analysis of the management and therapeutic performance of diabetes mellitus employing special target;World Journal of Diabetes;2023-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3